2012 Annual Meeting | Attention Deficit Hyperactivity Disorder Across the Lifespan

��ɫ��

2012 Annual Meeting | Attention Deficit Hyperactivity Disorder Across the Lifespan

Date Thursday 04/26/12

Time 06:30 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Martha B. Denckla, MD

Topic(s) Child Neurology and Developmental Neurology

Learning Objectives Participants should be able to recognize the clinical features of ADHD during key ages in the lifespan; understand the neurobiological basis and core neuropsychologic underpinnings of ADHD and their impact on clinical manifestations; know the available treatment options (pharmacologic and nonpharmacologic) for ADHD and common comorbid conditions at various ages; and determine treatment options when ADHD co-occurs with neurologic conditions such as tic disorder and epilepsy.

CME Available No CME available

Recommended Audience Other, Trainee, General Neurologist, Non-neurologist

Teaching Styles Didactic

Program Evaluations

Event Timeline
06:30 AM - 06:55 AM		Clinical Overview Martha B. Denckla, MD
06:30 AM - 08:30 AM		Break
06:55 AM - 07:25 AM		Attention to Motion: Insights into Impaired Behavioral Control in ADHD Stewart H. Mostofsky, MD
07:25 AM - 07:50 AM		Pharmacologic Management Max Wiznitzer, MD, FAAN
07:50 AM - 08:30 AM		Questions and Answers

Faculty Disclosures
Martha B. Denckla, MD	No disclosure on file
Max Wiznitzer, MD, FAAN	Dr. Wiznitzer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Department of Health and Human Services - Vaccine Injury Compensation Program. Dr. Wiznitzer has a non-compensated relationship as a Board of Directors with CHADD that is relevant to AAN interests or activities.
Stewart H. Mostofsky, MD	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��